China Healthwise Holdings Limited

348 KYG2120E1290

Pharmaceuticals

Market Closed - Hong Kong S.E. Other stock markets 01:38:28 24/05/2024 pm IST			5-day change	1st Jan Change
0.059 ^HKD	+3.51%		-15.71%	+43.90%

26/03	China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	CI
21/03	China Healthwise to Widen Losses in 2023	MT

Tranche Update on China Healthwise Holdings Limited's Equity Buyback Plan announced on June 16, 2020.

September 08, 2021 at 02:08 pm IST

From January 1, 2021 to June 24, 2021, the company has repurchased 0 shares, representing 0% for HKD 0 million. With this, the company has completed the repurchase of 20,950,000 shares, representing 2.72% for HKD 0.69 million under the buyback announced on June 16, 2020.

Latest news about China Healthwise Holdings Limited

China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2023	26/03	CI
China Healthwise to Widen Losses in 2023	21/03	MT
China Healthwise Holdings Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023	20/03	CI
China Healthwise Arm Picks Up 600,000 WellCell Shares	01/02	MT
China Healthwise Holdings' H1 Loss Widens on Higher Impairments	25/23/25	MT
China Healthwise Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2023	24/23/24	CI
China Healthwise to Widen H1 Loss	21/23/21	MT
China Healthwise Holdings Limited Announces Earnings Guidance for the Six Months Ended 30 June 2023	18/23/18	CI
China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2022	28/23/28	CI
China Healthwise Holdings Sees Narrower 2022 Loss; Shares Down 4%	27/23/27	MT
China Healthwise Unit Extends HK$9 Million Loan Facility to Eternity Investment	23/23/23	MT
China Healthwise Plans to Buy Land in Japan	18/22/18	MT
China Healthwise Terminates Acquisition Deal	28/22/28	MT
China Healthwise Turns to Net Loss in H1	26/22/26	MT
China Healthwise Holdings Limited Reports Earnings Results for the Half Year Ended June 30, 2022	25/22/25	CI
China Healthwise Holdings Limited Provides Unaudited Consolidated Group Earnings Guidance for the Half Year of 2022	21/22/21	CI
China Healthwise Expects H1 Loss; Shares Rise 3%	20/22/20	MT
China Healthwise Holdings Limited Provides Group Earnings Guidance for the Six Months Ended 30 June 2022	19/22/19	CI
China Healthwise to Acquire Entire Issued Share Capital in Powerful Select; Shares Fall 4%	13/22/13	MT
China Healthwise Holdings Limited Reports Earnings Results for the Full Year Ended December 31, 2021	28/22/28	CI
China Healthwise Holdings Limited Provides Earnings Guidance for the Year Ended December 31, 2021	21/22/21	CI
China Healthwise Unit Divests 6 Million Shares in IDG Energy	25/21/25	MT
China Healthwise Unit Offloads Shares in IDG Energy Investment	09/21/09	MT
Tranche Update on China Healthwise Holdings Limited's Equity Buyback Plan announced on June 16, 2020.	08/21/08	CI
China Healthwise Holdings Limited Announces Unaudited Consolidated Earnings for the Six Months Ended June 30, 2021	26/21/26	CI

Chart China Healthwise Holdings Limited

Duration

Period

More charts

Company Profile

CHINA HEALTHWISE HOLDINGS LIMITED, formerly Haier Healthwise Holdings Limited, is a Hong Kong-based investment holding company principally engaged in toy and electronic products businesses. The Companyâs main businesses include the development, design, manufacture and sales of toys, commercial kitchen products and consumer electronic products. It operates through three segments, including Manufacturing and Sale of Toys segment, Sale of Consumer Electronic Products segment, as well as Manufacturing and Sale of Commercial Kitchen Products segment. Its products include water purifiers, air conditioners, washing machines and infant formula preparation kits, among others.

Sector

Pharmaceuticals

Calendar

22/08/2024 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Pharmaceuticals Wholesale

	1st Jan change	Capi.
CHINA HEALTHWISE HOLDINGS LIMITED	+43.90%	5.82M
MCKESSON CORPORATION	+21.11%	72.89B
CARDINAL HEALTH, INC.	-4.38%	23.48B
SINOPHARM GROUP CO. LTD.	+4.16%	8.51B
SHANGHAI PHARMACEUTICALS HOLDING CO., LTD	+9.26%	8.42B
HUADONG MEDICINE CO., LTD	-24.53%	7.56B
H. LUNDBECK A/S	+13.31%	5.22B
EBOS GROUP LIMITED	0.00%	4.2B
GALENICA AG	-1.31%	3.91B
JOINTOWN PHARMACEUTICAL GROUP CO., LTD	+6.13%	3.91B